Phase III trial evaluating weekly paclitaxel versus docetaxel in combination with capecitabine in operable breast cancer.
Kelly CM, Green MC, Broglio K, Thomas ES, Brewster AM, Valero V, Ibrahim NK, Gonzalez-Angulo AM, Booser DJ, Walters RS, Hunt KK, Hortobagyi GN, Buzdar AU.
Kelly CM, et al. Among authors: hortobagyi gn.
J Clin Oncol. 2012 Mar 20;30(9):930-5. doi: 10.1200/JCO.2011.36.2079. Epub 2012 Feb 13.
J Clin Oncol. 2012.
PMID: 22331946
Clinical Trial.